Getting insurance after genetic screening on familial hypercholesterolaemia; the need to educate both insurers and the public to increase adherence to national guidelines in the Netherlands

. 2002 Feb;56(2):145–147. doi: 10.1136/jech.56.2.145

PMCID: PMC1732084 PMID: 11812815

Full Text

The Full Text of this article is available as a PDF (80.6 KB).

These references are in PubMed. This may not be the complete list of references from this article.

Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
Low L., King S., Wilkie T. Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom. BMJ. 1998 Dec 12;317(7173):1632–1635. doi: 10.1136/bmj.317.7173.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
Morrison P. J. Implications of genetic testing for insurance in the UK. Lancet. 1998 Nov 21;352(9141):1647–1648. doi: 10.1016/s0140-6736(05)61446-8. [DOI] [PubMed] [Google Scholar]
Motulsky A. G. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I3–I7. [PubMed] [Google Scholar]
Umans-Eckenhausen M. A., Defesche J. C., Scheerder R. L., Cliné F., Kastelein J. J. Opsporing van patiënten met familiaire hypercholesterolemie in Nederland. Ned Tijdschr Geneeskd. 1999 May 29;143(22):1157–1161. [PubMed] [Google Scholar]